Affiliations: [a] Department of Psychosomatic Medicine and Psychotherapy, University of Rostock, Rostock, Germany
| [b] Rudolf Zenker Institute for Experimental Surgery, University of Rostock, Rostock, Germany
| [c] Oscar Langendorff Institute of Physiology, University of Rostock, Rostock, Germany
| [d] German Center for Neurodegenerative Diseases (DZNE), Rostock and Greifswald, Germany
| [e] Centre for Transdisciplinary Neurosciences Rostock (CTNR), University of Rostock, Rostock, Germany
Correspondence:
[*]
Correspondence to: Prof. Dr. med. Stefan Teipel, Department of Psychosomatic Medicine and Psychotherapy, Rostock University Medical Center, Gehlsheimer Straße 20, 18147 Rostock, Germany. Tel.: +49 381 494 9470; E-mail: [email protected].
Abstract: Transgenic mouse models serve a better understanding of Alzheimer’s disease (AD) pathogenesis and its consequences on neuronal function. Well-known and broadly used AD models are APPswe/PS1dE9 mice, which are able to reproduce features of amyloid-β (Aβ) plaque formations as well as neuronal dysfunction as reflected in electrophysiological recordings of neuronal hyperexcitability. The most prominent findings include abnormal synaptic function and synaptic reorganization as well as changes in membrane threshold and spontaneous neuronal firing activities leading to generalized excitation-inhibition imbalances in larger neuronal circuits and networks. Importantly, these findings in APPswe/PS1dE9 mice are at least partly consistent with results of electrophysiological studies in humans with sporadic AD. This underscores the potential to transfer mechanistic insights into amyloid related neuronal dysfunction from animal models to humans. This is of high relevance for targeted downstream interventions into neuronal hyperexcitability, for example based on repurposing of existing antiepileptic drugs, as well as the use of combinations of imaging and electrophysiological readouts to monitor effects of upstream interventions into amyloid build-up and processing on neuronal function in animal models and human studies. This article gives an overview on the pathogenic and methodological basis for recording of neuronal hyperexcitability in AD mouse models and on key findings in APPswe/PS1dE9 mice. We point at several instances to the translational perspective into clinical intervention and observation studies in humans. We particularly focus on bi-directional relations between hyperexcitability and cerebral amyloidosis, including build-up as well as clearance of amyloid, possibly related to sleep and so called glymphatic system function.
